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Abstract 
 
Carissa lanceolata (conkerberry) is a perennial woody shrub used in traditional 
medicine by indigenous communities in Western Australia, the Northern Territory 
and Queensland for various medical conditions such as toothache, respiratory 
infections and the cleaning of sores, which all strongly indicate an antibacterial 
activity. A literature review revealed that the wood of this plant possesses significant 
antibacterial activity, which was found to be related to the presence of eudesmane 
type sesquiterpenes. C. edulis and C. carandus are frequently used in other 
traditional systems of medicine in different parts of the world, and thus have also 
been investigated for bioactive compounds and pharmacological properties. Some of 
these were found to be in line with the main findings of this work. 
Carissa lanceolata root was shown to exhibit significant antibacterial activity against 
both Gram negative and Gram positive organisms. A micro-broth dilution assay was 
performed on 96-well plates using resazurin as an indicator for microbial growth of 
Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis and Staphylococcus 
aureus. Bioassays carried out in this work showed that crude extracts of root bark 
and wood, particularly their polar constituents were more active against the four 
strains of bacteria tested. Chemical investigation of the root bark revealed that it 
contains a volatile oil, which was isolated by steam distillation as well as solid phase 
micro extraction. It was found to consist of a single compound, which was identified 
as 2'-hydroxy acetophenone. The identity of this compound was confirmed by 
GC/MS and 1H NMR spectroscopy. Furthermore, the eudesmane-type sesquiterpene, 
carissone, was isolated from the root bark DCM and root wood hexane extracts. Its 
chemical identity was confirmed by IR, 1H and 13C NMR spectroscopy. The lignan, 
carinol, on the other hand, was isolated from the moderately polar fractions of the 
root wood MeOH extract. The obtained IR and 1H NMR data as well as Rf values all 
correspond to the literature. Two other yet unidentified compounds were isolated, but 
further studies into their chemistry and antibacterial activity were not possible in this 
current study. The antibacterial activity of the isolated compounds was considerable, 
with 2'-hydroxy acetophenone exhibiting the strongest effect, followed by carinol 
and then carissone. 
 xiv
 1 Background  
 
The conkerberry, Carissa lanceolata R.Br (Apocynaceae) is commonly used in many 
Indigenous Australian communities across Northern Australia for the treatment of a 
variety of conditions such as chest pain, toothache, colds and flu1, 2. Elsewhere, other 
species of the family are also frequently used in traditional systems of medicine in 
different parts of the world. Of those, particularly C. edulis and C. carandas have 
been investigated for bioactive compounds and pharmacological properties (section 
1.3 and 1.4). C. lanceolata, however, has received considerably less scientific 
attention despite its important role in traditional native Australian medicine. To date, 
only the anti-microbial properties of the plant’s wood have been investigated in 
detail3. 
Guided by previous published work on members of the genus and the family 
(Apocynaceae), a bioassay-guided study using a micro broth dilution technique was 
carried out in this research project to extract and isolate anti-microbial compounds 
from root material of C. lanceolata. The structures of the isolated pure compounds 
were elucidated by a variety of instrumental techniques, most importantly Nuclear 
Magnetic Resonance (NMR) and infra-red (IR) spectroscopy as well as gas 
chromatography with mass selective detection (GC/MS). 
In the following, an overview of the botanical and chemical characteristics as well as 
the traditional medicinal uses and pharmacological properties of various Carissa spp. 
are provided with particular emphasis on the two most researched members of the 
genus, C. edulis and C. carandus, as well as C. lanceolata as the topic of this thesis. 
This background section is followed by a description of the materials and methods 
used in this project before its findings are presented and discussed. The concluding 
chapter summaries the major findings and outlines a future research agenda. 
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 1.1 The Genus Carissa 
 
The genus Carissa belongs to the order Gentianales (Apocynaceae)2. Generally, the 
Apocynaceae family, including the genus Carissa contains numerous plants that have 
been used in traditional medicine and / or have yielded pharmacologically active 
compounds4 (Table 1). Their botanical, chemical, medicinal and 
ethnopharmacological properties is discussed in the following sections in greater 
detail.  
 
Table 1: Ethnopharmacological use of Carissa species 
Species Part used Ethnopharmacological uses 
C. lanceolata Root 
Stem 
Leaves
Tooth ache, chest pain, cleaning sores1, 2 
Rheumatism1  
Cold and flu, as a mosquito repellent1, 2 
C. carandas Root 
Stem 
Leaves 
Fruit 
Stomachic, antidiarrheal, anthelmintic5-7
Strengthens tendons8
Fevers, earache, soreness and syphilitic pain5-7
Skin infections9 edible5,10
C. edulis Root 
 
 
Fruit 
Headache, chest complaints, rheumatism, 
gonorrhoea, syphilis, rabies, gastric ulcer, 
glandular inflammation11-14
Edible11 
C. spinarum Root 
Fruit 
Purgative, cleaning wounds in animals5  
Edible5
C. congesta Fruit Edible5
C. grandiflora  
(C. macrocarpa) 
Fruit Edible7
C. opeca Leaves Tanning agent5
C. bisponosa Fruit Edible5
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1.1.1 Habitat  
 
Thirty to thirty five Carissa species are found in Africa, Madagascar, the Arabian 
peninsula, the Indian subcontinent, New Guinea, New Caledonia and Australia. Of 
the four species occurring in Australia, three are considered endemic16 (Table 2). 
 
Table 2: Distribution of Carissa species5
Species Habitat 
C. lanceolata Australia 
C. ovata Australia, New Caledonia 
C. laxiflora Australia 
C. scabara Australia 
C. carandus  Indian subcontinent, South East Asia 
C. congesta Indian subcontinent, South East Asia 
C. gagentica Indian subcontinent 
C. grandiflora (C. macrocarpa) Indian subcontinent 
C. opeca Indian subcontinent 
C. spinarum Indian subcontinent (desert areas) 
C. bisponosa Indian subcontinent (desert areas) 
C. paucinervia Indian subcontinent (Himalayan regions) 
C. edulis Africa 
1.1.2 Morphology 
 
According to Foster16 members of the Carssia genus are evergreen perennial woody 
shrubs, scramblers or trees, producing a white latex. The stem has opposite, simple or 
forked spines. Leaves are petiolate and opposite, glabrous or with basifixed 
indumentum, collectors being absent. The inflorescence is terminal or extra-axillary, 
generally a pedunculate of umbelliform. Flowers are scented and pedicellate with the 
calyx lacking colleters. The corolla is of salverform with a cylindrical tube, usually 
somewhat bulging around the anthers. The flowers are normally glabrous or with 
internal and external indumentum, stamens are included, inserted near the top of the 
tube and not adherent to the style-head, while the anthers are linear to linear-
lanceolate. The style-head is subglobose and bifid at the apex. The fruit is a globose 
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to obloid-ovoid, syncarpus fleshy berry. It contains one to four seeds, which are 
flattened, globose, unwinged and ecomose16. 
1.1.3 Ethnopharmacology, Chemistry and Pharmacology 
 
The medicinal uses of C. lanceolata, the subject of this project, and also C. carandas, 
and C. edulis, which both have provided useful points of reference for this work, are 
discussed in detail in the ensuing sections. Medicinally of lesser importance, and 
therefore receiving considerably less attention in academic literature, are C. 
bispinosa, C. macrocarpa, C. congesta and C. spinarium. The latter produces edible 
fruits18, its roots are traditionally used for their purgative properties as well as to treat 
worm infested wounds in animals6. Leaf extracts of C. opeca, on the other hand, are 
used as a tanning agent6. Limited chemical and pharmacological studies have not yet 
been undertaken with those particular Carissa species, but lignans, sesquiterpenes of 
the eudesmane type and several cardiac glycosides have been isolated from them8. 
Moreover, in line with its traditional uses, leaves of C. opeca were found to contain 
tannins whereas the roots of C. spinarum were reported to contain caffeic acid while 
its leaves produce urosolic acid and naringin5. Carissone and the D-glucoside of β-
sitosterol were isolated from the roots of C. congesta18 and a new germacrane 
derivative, carenone, was isolated from the stems of C. spinarum. The leaves of the 
latter exhibited significant antibacterial activity against Gram negative organisms17 . 
Chloroform extracts of the same displayed strong antioxidant properties19. The 
alcoholic extracts of aerial parts of C. congesta, on the other hand, were found to 
have CNS depressant activity in mice21. The cardiotonic activity of C. spinarum was 
four to six times greater than that of C. carandus, which will be discussed in more 
detail in Section 1.322. 
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1.2 Carissa lanceolata R.Br. 
1.2.1 Habitat  
 
Carissa lanceolata R.Br. or conkerberry (conkleberry), is a poisonous plant found in 
the open woodlands and stony locations of tropical areas in Western Australia, the 
Northern Territory and Queensland24. Although occurring mostly in humid areas, it 
has also been found to a limited extent in some desert areas of central Australia16 
(Figure 1).  
 
 
 
Figure 1: Geographical distribution of C. lanceolata 
 
 (Source: Adapted from Forster PI. Flora of Australia: CSIRO Australia; 1996) 
 
 
1.2.2 Morphology  
 
Carissa lanceolata is a divaricately branched spiny shrub, which grows up to 2 m 
high, usually glabrous or minutely hairy. Its spines are spreading and straight, 5-7mm 
long. The leaves are of short petiolate, narrowly elliptic, usually glabrous, and 
abruptly acuminate. The cymes are often on short branchlets, axillary, where bracts 
are linear-subulate. Calyx lobes are subulate and acute, up to 2mm long, but often 
unequal in size. The corolla is white in colour, glabrous from the outside, but 
sparsely hairy inside. Its lobes are narrowly oblong and subacute. The style is 
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globular with two appendages. Young berries are red, turning black at maturity and 
are ovoid to globular in shape15 (Figure 2).  
 
Figure 2: Arial part of C. lanceolata 
 
 (Source: www.alicesprings.nt.gov.au) 
 
1.2.3 Ethnopharmacology 
 
The roots, leaves, bark and twigs of C. lanceolata have traditionally been used by 
indigenous communities of Western Australia (WA), Queensland and the Northern 
Territory (NT) of Australia. It has been used for the treatment of various medical 
conditions, including toothache, respiratory infections and the cleansing of sores, the 
causes of which could be bacterial. Some indigenous communities in the Kimberly 
area of WA burn leaves as a mosquito repellent and squeeze the wood of young 
plants to obtain a sap, which is rubbed on the skin for rheumatism. Decoction of 
leaves and twigs are also used by the Amanbidji community (Timber Creek Region, 
NT) for the treatment of colds and flu-like symptoms. The Lajamanu (CMB 
Lajamanu, NT) and Yuelamu (Mt. Allen Station, NT) communities prepare a wash 
from the young roots, which is then rubbed into the skin to treat chest pain. The same 
decoction is also used by the Borroloola community (Borroloola, NT) to treat 
toothache24.  
1.2.4 Chemistry 
In a previous study, crude extracts of the roots and stems (Figure 2 and Figure 3) 
have been reported to show antibacterial activity but no detailed follow up chemical 
analysis was ever undertaken. Furthermore, antibacterial compounds from the aerial 
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wood of C. lanceolata, isolated in a bioassay-guided study, have been reported by 
Lindsay et al.3  
With respect to its chemical constituents, thus far, the eudesmane-type sesquiterpene, 
carrisone, and the cardiac glycoside, odoroside H25, and have been isolated and 
identified from the roots of C. lanceolata25  
Figure 3: Root of C. lanceolata 
 
(source: School of Pharmacy, Curtin University) 
  
1.3 Carissa carandus Linn. 
1.3.1 Habitat  
Carissa carandas occurs in the drier sandy and rocky soils throughout the Indian 
subcontinent and South East Asia. It is commonly found in Southcentral India and 
Northern Sri Lanka6,7 .  
 
1.3.2 Morphology 
Carissa carandus is a small tree or a large shrub, with numerous, divaricate branches 
and very sharp horizontal spines, which are often branched. Its leaves are simple, 
opposite, oblong-oval or oblong-lanceolate, subacute at the base, obtuse at the apex, 
glabrous and thin. The flowers are regular and bisexual in threes. They are shortly 
stroked in clusters at the end of short, axillary and terminal peduncles, which are 
bract, small and linear with five fused puberulous sepals. The segments are linear or 
lanceolate, acute and ciliate, lapping to the right. There are five distinct stamens, 
inserted in the corolla tube, the ovary is superior to locular. The style is a simple 
stigma conical and the berries are smooth, ovoid and bluntly pointed, reddish-purple, 
with four seeds7 (Figure 4). 
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Figure 4: Aerial part of C. carandas 
 
(Source: www.pharmazie.uni-greifswald.de) 
 
1.3.3 Ethnopharmacology 
 
C. carandas is the best known member of the genus, as it has been used as a 
traditional medicinal plant over thousands of years in the Ayurvedic system of 
medicine as it is practiced on the Indian subcontinent5. Thus, traditional uses of C. 
carandas are well established. The root is credited with bitter, stomachic, 
antidiarrhoeal and anthelmintic properties, while its leaves are prescribed in remittent 
fevers, earache, soreness and syphilitic pain of the mouth6,7. A tincture of fruits is 
used in skin infections9 and a decoction of wood is employed as a tonic to strengthen 
the tendons of slim patients8. 
 
1.3.4 Chemistry  
 
The roots of C. carandas have yielded a number of volatile principles, including 2-
acetylphenol26,27. Pal et al. have reported a new lignan, carinol 28, from the root of C. 
carandas, whereas studies carried out by Rastogi et al. have led to the isolation of a 
mixture of sesquiterpenes, namely carissone and carindone, as a novel type of C31 
terpenoid29-30. The leaves were reported to have triterpenoidal constituents33, as well 
as tannins34, and a new isomer of urosolic acid, named carissic acid35, was also found. 
Fruits of this plant were demonstrated to contain a mixture of volatile principles36, 27 
including 2-phenyl ethanol, linalool, β-caryophyllene, isoamyl alcohol, benzyl 
acetate and a novel triterterpenic alcohol, carissol37. Enzymatic and mild hydrolysis 
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of polar glycosides from C. carandas yielded oderoside H, digitoxigenin and the 
sugars D-glucose and D-digitalose29. 
1.3.5 Pharmacology 
 
Pharmacological studies have identified cardiotonic activity in an alcoholic extract of 
root material and noted a decrease of blood pressure in normal anaesthetised cats38. 
The total crude plant extract produced an increase in free histamine in guinea pig 
lung and a pronounced decrease in blood pressure is known to be caused by the 
plant’s lipophilic fraction39. Isolated carissone derivatives exhibited an antizymotic, 
antibacterial and atropine like spasmolytic activity40. The lipase activity of fruits has 
also been studied41, while an aqueous extract of the root demonstrated anthelmintic, 
spasmolytic, cardiotonic and hypertensive action in a preliminary pharmacological 
screening undertaken by Zaki et al. 26 An antipyretic activity has also been reported 
for the same extract42.  
 
1.4 Carissa edulis Vahl 
 
1.4.1 Habitat  
C. edulis is found throughout the Arabian peninsula and occurs also in warm humid 
and hot dry areas of tropical Africa, the Transvaal, Botswana, north and northeast 
Namibia11. 
1.4.2 Morpholgy 
Carissa edulis (Figure 5) is a spiny, much branched, small tree, shrub or scrambler 
with a milky sap, which grows up to 5 m in height. Its bark is grey and smooth, 
young branchlets are with or without hairs. The spines are simple, straight and 
usually single. Its leaves are opposite and ovate to ovate-elliptic. They are coriaceous, 
dark green above and paler green below, glabrous to pubescent. Lateral veins are 
obscure, the apex is tapering often with a bristle-like tip, while the base is rounded to 
shallowly lobed, the margins are entire with a 1-4 mm long petiole. The sweetly 
scented flowers are white tinged with purple, red or pink, up to 1.8 cm long, about 2 
cm in diameter, slender and tubular, with the corolla lobes overlapping to the right. 
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Fruits are ovoid to almost spherical, red-black when young, upon ripening turning 
purplish black and contain two to four flat seeds11. 
 
Figure 5: Aerial parts of C. edulis 
 
 (Source: pharmazie.uni-greifswald.de) 
 
1.4.3 Ethnopharmacology 
C. edulis is a well-known African member of the Carissa genus commonly used in 
African folk medicine, especially in the northern and eastern countries of the 
continent14. Traditional applications include treatment of headache, chest complaints, 
rheumatism, gonorrhoea, syphilis and rabies12-14. The plant’s roots have been used in 
Africa for a variety of medicinal purposes. The vapour from a hot aqueous root bark 
infusion, for example, is inhaled as a treatment for chest congestion and the root is 
also applied as poultice to relieve toothache12, 13. In Ghana, the root bark is mixed 
with spices and used as an enema for lumbago and other pains, while root scrapings 
are used for glandular inflammation. Ground up roots are employed as a remedy for 
venereal diseases, to restore virility, to treat gastric ulcers, cause abortion and as an 
expectorant11. An infusion of roots along with other medicinal plants can be used to 
treat chest pains and a root decoction is also used for treating malaria11. 
1.4.4 Chemistry 
Carissone, cryptomeridiol, β-eudesmol , a sesquiterpene of the eudesmane type with 
a yet to be identified structure, and a germacrane derivate have all been isolated from 
the roots of this species43. Studies of Carissa edulis’ lignan fraction by Achenbach et 
al. resulted in the identification of carissanol, (-)-nortrachelogenin and carinol, other 
lignans found to be present are (+)-lariciresinol , (-)-scoisolariciresinol and               
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(-)-olivil44. The roots also contain 2’-hydroxy acetophenone, vanillin, 4-hydroxy-(3-
hydroxypropionyl)-benzene, coniferaldehyde, scopoletin, isofraxidin and 
catalponol44,45. Furthermore, another study has identified the presence of γ-
eudesmol46. The inositol derivative quebrachitol in the twigs and an alkaloid in the 
stem and leaves have also been reported46. 
1.4.5 Pharmacology 
In pharmacological studies, root wood extracts were found to induce a diuretic effect 
in rats48. Furthermore, an extract of the leaves of C. edulis significantly reduced the 
blood glucose level in streptozotocin diabetic rats, indicating the presence of 
compounds with hypoglycaemic activity49. Aqueous extracts of C. edulis have 
exhibited significant activity against the Herpes simplex virus (HSV) in vitro and in 
vivo for both wild type and resistant strains of HSV50. 
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 1.5 Reported compounds 
In the following section, key compounds isolated from the various Carissa species 
are discussed in more detail with respect to their chemistry. 
1.5.1 Sesquiterpenes 
Sesquiterpene are C15 compounds biogenetically derived from farnesyl 
pyrophosphate 51 (Figure 6). 
 
 
Figure 6: Biogenesis pathway of sesquiterpenes51
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CH3
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H
+
+
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 Sesquiterpenes of the eudesmane type (1), such as Carissone (2), are one of the 
genus’ characteristic compounds, but they have also been isolated from genera other 
than Carissa, for instance from Makania banisteriae52, Allophylus laevigatus53, 
Persea japonica54 and Eucalyptus macarthuri55. When inoculated with TMV virus, 
Nicotina undalata leaves were found to produce stress compounds including 
dehydrocarissone (3) together with another 18 sesquiterpenes56. In general, 
sesquiterpenes are known to possess antimicrobial, antineoplastic and anti-
inflammatory actions47. Eudesmanoids from Parthenium argentatum and P. 
tomentose were, for instance, shown to exhibit a significant antifungal effect57. 
 
 
Figure 7: Sesquiterpenes from Carissa spp 
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Carissone (1) was obtained by complete synthesis using santonin as a starting 
material58 and has also been synthesised from eudesmol for the purpose of 
establishing its absolute stereochemistry59. A series of substituted hydrazones, 
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carbohydrazones and thiocarbohydrazones have also been synthesised using 
carissone, α-cyperone, 4,5-dihydrocarissamine and 5-cyanocarissone as starting 
materials59. 
Carindone (4) is a new C31 type terpenoid isolated from C. carandas and                    
C. lanceolata, which displays a significant antimicrobial activity3.  
1.5.2 Lignans  
Biogenetically, lignans are derived from the Shikimic acid - Cinnamic acid pathways, 
followed by a series of enzymatic reactions to form these dimeric molecules60. They 
display antimicrobial and antioxidant activities due to their polyphenolic nature61. 
Lignans reported from Carissa species44 also commonly occurring in trees of both, 
Gymnospermae and Angispermae 61. The lignan carinol (7) was first isolated from C 
carandas28, while carissanol44 (8) was obtained from C. edulis. Other lignans 
reported from C. edulis44 are secoisolariciresinol (9), nortrachelogenin (10) and olivil 
(12) as shown in figure 8.  
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Figure 8: Lignans identified from Carissa spp. 44
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1.5.3 Other isolated compounds  
2-Hydroxy acetophenone (13) has been isolated by steam distillation from the fresh 
root bark of C. edulis45. Although floral extracts of C. carandas were free from 2-
hydroxy acetophenone, they contained many other volatile compounds36 such as 
vanillin (17), scopoletin (16), coniferaldehyde (15), γ-eudesmol and 4-hydroxy-(3-
hydroxypropionyl)benzene (14) which are illustrated in figure 9. 
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Figure 9: Other compounds isolated from Carissa spp. 
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Odoroside H (18), odoroside G, evomonoside and perhaps two other as yet 
structurally unidentified cardiac glycosides are responsible for the observed 
cardiotonic activity of C. carndas and C. spinarum 22. Moreover, stem bark and 
leaves of C. spinarum have been reported to contain sitosterol, lupeol and urosolic 
acid17. Odoroside H has also been isolated and reported from C. lanceolata roots by 
Mohr et al25. 
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1.6 Antibacterial activity 
Roots of Carissa species are often used in traditional systems of medicine due to 
their antibacterial activities (Table 1). C. lanceolata root, for instance, is used by 
many Aboriginal communities in central and northern Australia to treat toothache 
and to clean sores. The root of C. edulis is used as an antiseptic in Ghana, while in 
East and Northern African folk medicine it plays an important role in treating 
syphilis and gonorrheae. C. carandas root is prescribed in the Ayurvedic system of 
medicine as an antidiarrheal and anthelmintic. Indian farmers use a decoction of C. 
spinarum to clean the infected and worm infested wounds of livestock. The above 
mentioned medicinal applications of the root strongly suggest an activity against 
bacteria. It is therefore of interest to follow up on this lead and screen members of 
the Carissa family for antimicrobial compounds. With respect to C. lanceolata, this 
was one objective of this work. 
 
1.6.1 Assay Methods 
Mainly three methods are used in plant drug analysis to screen for and assess 
antibacterial or antimicrobial activities. The two more conventional methods65 are 
disc diffusion and well diffusion assays, where the microbes to be studied are 
inoculated to semisolid media and test samples are introduced to diffuse into the 
media. Disc diffusion uses cellulose discs, which are treated with the test sample 
dissolved in a suitable volatile solvent. The dried discs are kept in contact with the 
inoculated media to allow diffusion before being incubated to promote bacterial 
growth. In the well diffusion method, small circular wells are cut into the solidified 
inoculated media. These wells are then filled with the sample solution using a 
suitable inert solvent. The solution is allowed to diffuse into the media for a short 
time before incubation. In both diffusion assay types antimicrobial activity is 
assessed as a measure of the width of a zone of inhibition of growth around the 
sample (on the disk or in the well), which can also be correlated to the strength of the 
test solution to establish minimal inhibitory concentration (MIC) values. 
An alternative method used in this study is the micro broth dilution method66. Its 
principle is similar to the above procedures, but it operates on a much smaller scale 
(volumes in µL and test samples used in µg amounts). The sample is introduced to an 
inoculated liquid media, in which the compound will be diluted and dispersed. After 
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incubation of this solution for the respective time, microbial growth can be observed 
by turbidity or using a suitable dye. In the latter procedure, the intensity of the colour 
formed can be measured by spectrometry to quantify the antimicrobial activity. In all 
cases serial dilutions are used to calculate MIC values. 
Micro broth dilution was found to be an efficient and reliable method, with the 
additional advantage of requiring only minimal quantities of test samples. Using 96 
well plates (ELISA plates); a serial dilution can also be performed simultaneously for 
many compounds at one time, allowing a qualitative and a quantitative assay in a 
single, very time efficient step. As a result, MIC values for many compounds against 
one particular strain can be obtained from a single experiment and even multiple 
studies can be performed in the same plate to validate results66.  
Taking into account these advantages, the antibacterial activity of C. lanceolata was 
therefore studied by micro broth dilution assay in this project using the above 
described microbroth dilution method on 96-well plates. Resazurin was used as 
indicator for microbial growth, which has frequently being an accurate and 
convenient method providing qualitative and quantitative results in a single step66. In 
a serial dilution sequence, the margin between growth and inhibition was clear 
enough to determine the MIC from either bactericidal or bacteriostatic activity, since 
reduction of blue coloured resazurin to pink colour resorufin was observed as an 
indication of microbial growth, while a persisting blue colour in the test solution 
demonstrated antimicrobial activity66 (Figure 10). This method was found to be 
superior to the conventional disc diffusion and well diffusion methods67-70 (Appendix 
III). 
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1.6.2 Bacterial Strains used in the Antibacterial Bioassay 
As a member of the Enterobacteriaceae family, morphologically E. coli are short rod 
shaped Gram negative bacteria, which are commonly found as intestinal flora. E. coli 
endotoxins can cause urinary tract infections, diarrhoea, sepsis and meningitis when 
found outside the intestine. They are sensitive towards a wide range of antibiotics 
and other antimicrobial agents, but tend to be resistant to β-lactam antibiotics, 
trimethoprim and vancomycin due to mutations. E. coli cultures grown on nutrient 
agar plates are smooth, circular, domed shape colonies71. 
S. aureus, on the other hand, is a member of the Staphylococci family. Being a Gram 
positive cocci, it is found on dermal and mucosal flora. S. aureus is different to other 
members of the family insofar as it is the only coagulase positive Staphylococci. It 
causes aggregation of the bacteria by bonding to fibrinogen so the bacteria cell is less 
likely to be ingested by phagocytes. β-Lactam antibiotic resistance is evident due to 
the presence of mecA gene; furthermore, it also shows resistance to tetracyclines. 
Colonies of S. aureus appear smooth, round, raised and have a wet look71. 
The genus Bacillus includes large aerobic, Gram-positive rods occurring in chains. 
Most members of this genus are saprophytic organism prevalent in soil, water and air 
and on vegetation, some are pathogens. Typical cells have square ends and are 
arranged in long chains, spores are located in the centre of the nonmotile bacilli, its 
colonies have a cut glass appearance71. 
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Pseudomonas, on the other hand, is a Gram negative bacterium, widely distributed in 
soil and water. P. aeruginosa sometimes colonises and causes diseases in humans, 
but is normally present in intestine flora. It is motile and rod-shaped, occurs as single 
bacteria, in pairs and occasionally in short chains71. 
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2 Materials and Methods 
2.1 Plant Material  
Plant material was collected in Broome, Western Australia during the month of 
March 2005 by Mr. Kim Courtenay of Kimberly TAFE. It was sent to the School of 
Pharmacy, Curtin University of Technology, where a voucher specimen was 
deposited. 
The root bark was separated from the root wood and both samples were dried at 37oC 
for 24 hrs. The size of the plant particles was reduced to less than 3 mm by Hammer 
mill (DHF-48, Universal Scientific Company, WA, Australia) using a 3 mm sieve. 
2.2 Solvents  
The following solvents mentioned in the table 3 were used in the various experiments 
of this work: 
Table 3: List of solvents used in the study 
Solvent Grade Supplier 
Dichloromethane HPLC Labscan Asia Co., Ltd.  
Hexanes Analytical Reagent Mallinckrodt Baker Inc. 
Methanol HPLC Labscan Asia Co., Ltd.  
Ethyl acetate Analytical Reagent Selby Scientific.  
Acetone Analytical Reagent Mallinckrodt Baker Inc. 
Petroleum Ether 40 – 70oC Analytical Reagent Merck Pty. Ltd. 
Ethanol Analytical Reagent CSR Distilleries Ltd. 
Chloroform Analytical Reagent Merck Pty. Ltd. 
2.3 Extractions 
2.3.1 Steam Distillation 
Fresh root bark (13.07g) was subjected to steam distillation. Steam was introduced to 
an aqueous suspension of the sample, which was maintained at 100oC. Generated 
vapours were condensed by cooling and collected for 1.5 hrs. As no distinct volatile 
oil droplets had separated, the aqueous distillate was extracted three times with 25 
mL DCM. The organic bottom layer was dried over anhydrous sodium sulphate, the 
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drying agent filtered off and the solvent carefully evaporated at room temperature. A 
resultant residual oil of 7.2 mg was collected. 
2.3.2 Solid Phase Micro-Extraction (SPME) 
One gram of fresh root bark was placed in a vial and a micro fibre was inserted into 
the vial with the help of a micro-fibre holder (Supelco Lot 248317). This setup was 
kept at 37oC for 30 min before the micro fibre was introduced into the GC/MS for 
analysis.  
2.3.3 Solvent Extraction  
Root wood (58.310 g) and root bark (32.971 g) were separately extracted in a 
Soxhlet apparatus. Hexane, DCM and MeOH (1L each) were used to extract the 
samples successively. Extracts obtained were concentrated by rotary vacuum 
evaporation at 50o C (Rotavapor 200, Büchi, Switzerland), then further dried under 
vacuum at ambient temperature using a vacuum oven (National Appliances, Oregon, 
USA). Dried extracts were stored in sealed vials at 4o C until used for further analysis. 
2.4 Chemical Tests 
Extracts were dissolved in 70% acetone to a final concentration of 50 mg/mL in 
order to perform the following chemical tests: 
2.4.1 Determination of Alkaloids 
One millilitre of the test solution was treated with a few drops of Dragendroff’s 
reagent (Appendix II). Another aliquot (1 mL) was treated with a few drops of 
Mayer’s reagent (Appendix II). The formation of a precipitate was seen as indicating 
the presence of alkaloids72, 73. 
2.4.2 Test for Saponins 
One millilitre aliquots of the various plant extracts were combined with 5 mL of 60o 
C water, then shaken for 2 min. As saponins are known to possess frothing activity72, 
the volume of froth produced in this experiment was observed and recorded every 10 
min for a total period of 30 min. 
2.4.3 Test for Phenolic Compounds 
One millilitre of test solution was treated with 10% ethanolic ferric chloride. 
Phenolic compounds were considered present when a colour change to blue green / 
dark blue was observed72, 73. 
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2.4.4 Test for Anthraquinones 
The Bornträger Test72 was used for the detection of anthraquinones. Two millilitre of 
the test sample was shaken with 4 mL of hexane. The upper lipophilic layer was 
separated and treated with 4 mL of dilute ammonia. If the lower layer changed to 
violet to pink was indicated the presence of anthraquinones. 
2.4.5 Test for Steroids  
One millilitre of the respective plant extract was treated with three drops of acetic 
anhydride and one drop of concentrated sulphuric acid. A colour change from deep 
green turning to brown to dark brown, indicated the presence of sterols72, 73 . 
2.4.6 Cardiac Glycosides 
Following the protocol of the Keller-Killiani Test72, 73, 1 mL of sample solution was 
mixed with One millilitre of glacial acetic acid then treated with one drop of 5% 
ethanolic ferric chloride solution. One millilitre of concentrated sulphuric acid was 
carefully poured down the side of the test tube. The appearance of a brownish ring 
between the two formed layers with the lower acidic layer turning blue green upon 
standing indicated the presence of cardiac glycosides. 
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2.5 Chromatographic Methods 
2.5.1 Thin Layer Chromatography (TLC) 
Thin layer chromatography was used to profile extracts and collected column 
fractions and also to analyse the isolates qualitatively by comparing their Rf values 
with published data. Silica gel F254 aluminium backed plates of 20 cm by 10 cm were 
used for the TLC experiments (Macherey-Nagel GmbH &Co. KG. Duren, Germany). 
A total of 4 µL of sample solution was either introduced to the plates using a 
Linomat IV (Camag, Switzerland) autosampler through a 100 µL syringe (Camag, 
Switzerland), or manually spotted onto the stationary phase using a glass capillary. 
The following solvent systems were used as mobile phase (table 4): 
 
Table 4: Mobile phases used in TLC 
S. No Solvents Ratio 
1 Hexane : Ethyl acetate 7:3 
2 Hexane : Ethyl acetate 5:5 
3 Hexane : Ethyl acetate 3:7 
4 Pet. Ether (40 -70): Ethyl acetate 3:7 
5 Ethyl acetate : Methanol 8:2 
6 Chloroform : Methanol 8:2 
7 Chloroform : Methanol 9:1 
8 Chloroform : Ethyl acetate 1:4 
9 Methanol : Ethyl acetate : Water 1:8:1 
10 Methanol : Ethyl acetate : Water 2:7:1 
 
Developed plates were dried and assessed at 254 and 366 nm (Alltech UV Cabinet 
CM10 Spectroline). Anisaldehyde (BDH Chemicals, Poole, England) spray 
(Appendix II), 5% sulphuric acid in ethanol and iodine vapour were also used as 
visualisation techniques. 
2.5.2 Column Chromatography 
DCM and MeOH extracts were further separated by column chromatography using 
glass columns with sintered glass filters. Silica gel (60-120 mesh, Merck KGaA, 
Darmstadt, Germany) was loaded as slurry prepared in the respective solvent. 
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Fractions were collected under gravitational flow. Purification columns were also run 
in a similar manner using neutral alumina (Sigma Chemicals Co., St. Louis, MO, 
USA) as stationary phase. 
2.5.2.1 Dichloromethane Extracts 
An aliquot of the DCM extract of the root bark (1.4 g) was incorporated into 2.8 g of 
silica gel, and then separated over 141.4 g of silica gel (column length 176 mm, 
diameter 30 mm, bed volume 210 mL). DCM, EtoAc and MeOH were subsequently 
used as mobile phases in a gradient system with a 10% increase of each subsequent 
solvent. Hundred millilitres of each mobile phase was used and 20 mL fractions were 
collected. The collected fractions were pooled according to their TLC profile 
(solvent system 4) to obtain five major fractions. Fractions 2 and 3 were further 
separated as described below. 
2.5.2.1.1 Fraction 2 
Fraction 2 (134 mg) was dissolved in DCM and wet loaded onto a suitably sized 
column (length 110 mm, diameter 15 mm, bed volume 20 mL) containing 13.4 g of 
silica gel as stationary phase. Petroleum ether and DCM were used in a gradient 
system as mobile phase with a 10% increase of each subsequent solvent. Twenty 
millilitre of each mobile phase were used and 10 mL fractions were collected. Five 
distinct fractions were identified and the second of those fractions was further 
separated by preparative TLC. 
2.5.2.1.2 Fraction 3 
A total of 209 mg of Fraction 3 were dissolved in DCM (2 mL) and wet loaded onto 
20.9 g of silica gel (column length 205 mm, diameter 15 mm, bed volume 31 mL). 
DCM and ethyl acetate were used as mobile phase in a gradient system with a 10% 
increase where 20 mL of each mobile phase was used, followed by an isocratic 
system of 100 mL of EtoAc and ethanol (1:1). Ten millilitres fractions were collected 
from both systems and pooled according to their TLC profiles to obtain three major 
fractions. The second of those fractions was separated on a preparative TLC plate.  
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 2.5.2.2 Methanol Extracts 
A MeOH extract of the root wood (3.674 g) was separated over 100 g of silica gel 
after incorporating the sample into 7.35 g of silica gel (column length 150 mm, 
diameter 30 mm, bed volume 150 mL). EtoAc and MeOH were used as mobile phase 
in a gradient system with a 10% increase. Hundred millilitres of each mobile phase 
was used and 20 mL fractions were collected. Four distinct fractions (Fractions 1-4) 
were identified. 
The first fraction (0.846 g) was dissolved in 3 mL of MeOH then wet loaded and 
separated by chromatography over 30 g of silica gel (column length 280mm, 
diameter 15 mm, bed volume 45 mL) using MeOH:DCM (1:1) as mobile phase. The 
fraction of interest (0.641 g) was eluted with EtoAc: DCM (4:1) over 30 g of silica 
gel, introduced as a solution in 2 mL of MeOH (column length 280mm, diameter 
15mm, bed volume 45 mL). The fraction of interest (0.444g) was further purified on 
10 g of silica gel (column length 100mm, diameter 15mm, bed volume 15 mL) with 
MeOH: DCM (98:2) followed by another column chromatography on 2g of silica gel 
(column length 50 mm, diameter 7 mm, bed volume 3 mL) with EtoAc: DCM (1:1) 
as mobile phase.  
 
2.5.2.3 Hexane Extracts 
2.5.2.3.1 Root Bark Hexane Extract 
A hexane extract (934 mg) was incorporated into 1.87 g of silica gel then introduced 
to 45 g of silica gel using a suitably sized column (length 70 mm, diameter 30 mm, 
bed volume 67 mL). It was separated using a gradient system of hexane, DCM and 
EtoAc as mobile phase with a 10% increase of each subsequent solvent. Sixty 
millilitres of each mobile phase were used and 20 ml fractions were collected. After 
pooling various fractions based on an identical TLC profile (Solvent system 4), 
Fraction 2 was further separated on 25 g of silica gel by wet loading (column length 
220 mm, diameter 15 mm, bed volume 31 mL) using DCM with increasing 
concentrations of EtoAc (5% gradient) as mobile phase. The isolated compound was 
further purified over a 5 g of alumina column (column length 75 mm, diameter 7 mm, 
bed volume 15 mL) using DCM as mobile phase.  
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2.5.2.3.2  Root Wood Hexane Extract 
Total of 1.14 g of root wood hexane extract was incorporated in 2.28 g of silica gel, 
then loaded onto 114 g of silica gel (column length 143 mm, diameter 15 mm, bed 
volume 171 mL), 20 mL each were collected from DCM with increasing amounts of 
EtoAc (5% per gradient step) as mobile phase. After studying their TLC profiles 
(Solvent system 4), the fractions were pooled to obtain three major fractions. The 
third fraction was separated subsequently by column chromatography on 20 g of 
silica gel (column length 200 mm, diameter 15 mm, bed volume 30 mL) using DCM 
as mobile phase. The compound isolated from this procedure was further purified 
with EtoAc over an alumina column (alumina 5g, column length 75 mm, diameter 7 
mm, bed volume 15 mL). 
2.5.3 Preparative TLC 
Preparative TLC plates (Analtech Uni Plate, Silicagel G, 400 cm2) of 2000 µm 
thickness were used in this study. Samples (100 mg/mL) were spotted onto the 
preparative TLC plate using a Linomat IV auto sampler through a CAMAG 500 µL 
syringe. Plates were developed in Solvent System 4 as mobile phase. A 1cm wide 
area of the developed chromatogram was exposed to anisaldehyde spray and heated 
in a hot air stream. The rest of the plate was covered with aluminium foil and a 
ceramic tile was placed on top for insulation to visualise the separation. The 
corresponding untreated areas of the remainder of the plate were scraped off and the 
compounds extracted from the stationary phase with a suitable solvent.  
This technique was employed to separate compounds from Fraction 2 of the root 
bark DCM extracts, which had in an earlier step been obtained by column 
chromatography (Section 2.5.2.1.1).  Fraction of 50 mg containing the compound of 
interest was dissolved in 500 µL of DCM and introduced to the preparative TLC 
plate. After development, the compounds on the plate were visualised, the band 
containing the compound of interest was scraped off and dispersed in DCM. The 
dispersion was filtered and the solvent evaporated to obtain the pure compound. 
In total, 88 mg were obtained from Fraction 3 obtained after column chromatography 
of the root barks DCM extract. Total 50 mg of the sample was dissolved in 500 µL of 
DCM and then introduced to a preparative TLC plate. A compound of interest was 
isolated in the same manner as described above using DCM as the solvent to extract 
from silica gel.  
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2.5.4 Gas Chromatography 
Gas chromatography-mass spectroscopy was used to identify those isolated 
compounds, which were thermostable and volatile using a Hewlett Packard 5890 
instrument with a HPMS 5 Column (Agilent Technologies, 30 m length, 0.25 mm 
internal diameter). 
Helium was used as the mobile phase with a flow rate of 0.9 mL/min under a 
pressure of 7.0 psi. The injection port temperature was kept at 120oC with the 
starting temperature of the column set at 60oC increasing to a final temperature of 
250oC over a period of 26 min. The detector temperature was kept at 280oC.  
2.6 Spectroscopy 
2.6.1 Infrared Spectroscopy (IR) 
Fourier transformation infrared spectroscopy (Perkin-Elmer Spectrum One) was used 
for spectroscopic analysis of some samples. These were dissolved in DCM or 
acetone then loaded onto sodium chloride discs (500A3 NaCl, Buck Scientific, CT, 
USA) and dried before their IR spectrum was recorded. 
2.6.2 Mass Spectroscopy (MS) 
Fractions separated by GC were detected by a Hewlett Packard Mass Selective 
Detector 5971. The detected compounds were identified by HP Chem Search 
Libraries (Wiley 275) as well as by careful analysis of the obtained fractionation 
pattern. 
2.6.3 Nuclear Magnetic Resonance Spectroscopy (NMR)  
Preliminary 1H NMR spectra were recorded on a Varian Gemini 200 MHz NMR 
spectrometer. More detailed 1H and 13C NMR spectra of selected compounds were 
provided by Dr. Lindsay Byrne (School of Biomedical, Biomolecular and Chemical 
sciences, University of Western Australia) using a Bruker Advance 500MHz NMR 
spectrometer. Samples were dissolved in deuterated solvents such as d-chloroform 
(Cambridge Isotopes, Andover, MA, USA) and d-acetone (Sigma-Aldrich Chemicals 
St. Louis, MO, USA) 
2.7 Antimicrobial Assay 
Antimicrobial assays were carried out in the Microbiology Facilities within the 
School of Pharmacy, Curtin University of Technology. Aseptic conditions were 
maintained using sterile equipment and substances. 
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2.7.1 Microbial strains 
Bacterial strains used in the study were selected based on their availability and 
previous use reported in similar studies. The selected strains were Escherichia coli 
(W), Bacillus subtilis (ATCC 6633), Pseudomonas auriginosa (ATCC 19429) and 
Staphalococous aureus (ATCC 6538P). 
2.7.2 Assay Material 
Microbial assays were performed on 96-well plates (Polystyrene High Transparency) 
supplied by Bioster s.p.a, PD, Italy. Nutrient broth was used as the media (Oxoid Ltd. 
Basingstoke, Hampshire, England) and resazurin sodium (obtained from BDH 
Chemicals, Poole, England) as indicator. Water used in the experiments was filter 
purified with MilliQ Filters then autoclaved for sterilisation. Streptomycin sulphate 
(Glaxo Australia Pty. Ltd. VIC Australia) was employed as the positive control. 
Extracts and isolates were dissolved in 70% acetone with 0.2% 
polyoxyethylenesorbitan monooleate (Tween 80) (Sigma Chemicals St. Louis, MO, 
USA) as a suspending agent.  
2.7.3 Assay Method 
Liquid media was inoculated with a single colony then incubated over night before 
being diluting 10 fold with sterile saline solution. Stock solutions of each extract and 
fraction (100 mg/mL) were prepared using 70% acetone with 0.2% Tween 80 as 
solvent mixture. Serial dilutions were then carried out in the wells as outlined (Table 
5) to obtain the given concentrations.  
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 Table 5: Volume of media and sample in wells 
Volume of 70% 
Acetone 
(μL) 
Volume of 
Extract 
(μL) 
Volume of 
Culture  
(μL) 
Concentration 
(mg/ mL) 
0 20  
(blank solvent) 
60 25 
0 20 60 25 
4 16 60 20 
8 12 60 15 
12 8 60 10 
16 4 60 5 
18 2 60 2.5 
19 1 60 1.25 
20 0 60 0 
 
All assays were performed in triplicate and separate plates were used for each strain 
to avoid cross-contamination. Streptomycin 10 mg/mL was used as a positive control 
and pure solvent as negative control. 
Plates were incubated for 18 hrs at 37oC. Then, 120 μL of sterile saline solution was 
added to each well to dilute the concentration to enable visualisation of any 
subsequent colour change. Volume of 5μL 0.01 % resazurin sodium solution (in 
Milli-Q water) was added to each well and the plates incubated for 60 min. The 
reduction of the dye with subsequent colour change from blue to pink was observed 
in samples with bacterial activity. Blue coloured wells indicated an antibacterial 
activity, and allowed also the determination of the MIC of the respective compound.   
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3 Results & Discussion 
3.1 Extraction 
Table 6 lists the amounts of extracts obtained in the various extraction procedures 
with the percentage yield calculated with reference to the dried plant material used.  
 
Table 6:  Extracts and their percentage yield 
Plant source Solvent Amount 
(in g) 
Percentage 
Yield 
Extract 
Number 
hexane 0.528 1.60% 3 
dichloromethane 0.456 1.38% 4 
Root Bark 
(32.971 g) 
methanol 5.250 15.92% 5 
hexane  0.934 0.53% 3 Root Bark 
(175.080 g) dichloromethane 1.414 0.81% 4 
hexane 1.115 1.91% 6 
dichloromethane 0.558 0.96% 7 
Root Wood 
(58.310 g) 
methanol 4.224 7.24% 8 
 
 
As is apparent from Table 6, MeOH extracts were highest in yield. A second larger 
scale extraction of root bark using hexane and DCM was carried out to obtain more 
material for the various separation and isolation procedures carried out in this project.  
3.2 Preliminary phytochemical studies  
3.2.1 TLC screening 
Extracts were studied for their TLC pattern with different solvent systems. The most 
efficient mobile phase system for hexane and DCM extracts was found to be EtoAc: 
petroleum ether (7:3). The chromatograms observed under UV254 and UV366 (TLC-1) 
and after visualisation with anisaldehyde spray (TLC-2) (Figure 11). MeOH extracts 
demonstrated the best resolution of compounds using an EtoAc : chloroform (4:1) 
solvent system for their moderately polar compound fraction (TLC-3), while more 
polar substances were separated best by an EtoAc : MeOH : water (7:2:1) mixture 
(TLC-4). 
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Figure 11: TLC in different solvent systems and visualisations 
          
 (TLC-1)  (TLC-2) 
 
 
     
 5                            8   
   5          8   
 (TLC-3)  (TLC-4) 
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3.2.2 Chemical tests 
Basic chemical tests were performed to identify the presence / absence of certain 
compound classes in the various extracts. As can be seen from the obtained results 
(Table 7), root wood and bark appear to contain alkaloids, which are extractable by 
MeOH what might indicate a polar character. Phenolic compounds were 
demonstrated in MeOH and, to a lesser extent, also in the DCM extract of root wood 
as well as in the MeOH extract of root bark material. MeOH extractable saponins 
were found to be present in the root bark. Test for steroids were positive for both 
wood and bark MeOH extracts, while only wood extracts were positive for cardiac 
glycosides. None of the extracts tested positive for anthraquinones. 
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Table 7: chemical tests 
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3.3 Volatile oil [#1] 
Steam distillation of 13.07 g of fresh root bark provided 7.2 mg of volatile oil (Figure 
12). The total percentage of oil was thus found to be 0.55%. The sample obtained 
from this procedure as well as the parallel conducted experiment of solid phase micro 
extraction (SPME) of fresh root material by micro fibre technique [#2], were 
analysed by GC/MS. Gas chromatography trace and mass spectra for both extracts 
suggested a single compound. Careful analysis of its fragmentation pattern in 
combination with comparison of the obtained data with the HP Chem©, Wiley 275 
©library identified the compound as 2′-hydroxy acetophenone (#1.1) (CAS number 
118-93-4) with a 91% level of confidence. 1H NMR analysis further confirmed this 
structure (see Section 3.7.1). 
 
 Figure 12: Isolation path of the C. lanceolata root 
C. lanceolata Root 
Fresh Bark Dried Bark Dried WOOD
#1 #2
#3 #4 #5
#6 #7 #8
Hexane 
Hexane
DCM
DCM 
MeOH
MeOH
Soxhlet Extraction
Soxhlet Extraction 
Steam 
distillation SPME
#1.1
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 3.4 Dichloromethane Extracts [#4] 
DCM extracts of the root bark were selected for this study, as the root wood’s DCM 
extracts exhibited a TLC pattern similar to the corresponding MeOH extracts. A 
sample of extract (1.414 g) was separated on silica gel by column chromatography 
using a solvent gradient with increasing polarity (DCM, EtoAc to MeOH in 10% 
steps). After pooling based on the TLC pattern obtained with Mobile System 4, four 
distinct fractions were obtained of which Fraction 2 and Fraction 3 were further 
studied (Figure 13). 
 
 
Figure 13: Isolation path for DCM extracts 
Root Barks DCM extract 
4
4.1 4.2 4.3 4.4
4.3.1 4.3.2 4.3.3
4.2.2.1 
4.3.2.1 
DCM>EtOAc>MeOH (10%) 
DCM>EtOAc>MeOH (10%) EtOAc:EtOH (1:1) 
Prep TLC – Mobile Phase 4 
4.2.1 4.2.2 4.2.3 4.2.4 4.2.5
Prep TLC – Mobile Phase 4 
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 3.4.1 Fraction 2 [#4.2] 
A total of 134 mg of Fraction 2 was again subjected to column chromatography on 
silica gel using the same mobile phase system (DCM, EtoAc to MeOH in 10% steps) 
to obtain five fractions. The second fraction [#4.2.2] was initially tried to be further 
purified by column chromatography using increasing concentrations of DCM in 
petroleum ether as mobile phase and silica gel stationary phase. Since this procedure 
was unsuccessful in separating the constituting compounds, preparative TLC was 
performed as the compounds were sufficiently resolved when developed in Mobile 
Phase 4. A volume of 500 µL of a 50 mg/mL sample was spotted on to the 
preparative TLC plate, which was then developed in a vapour-saturated chamber 
using EtoAc : petroleum ether (7:3) as mobile phase. A major spot quenching at 254 
nm with a purplish appearance upon spraying with anisaldehyde reagent was 
identified as the sole compound of this fraction [#4.2.2.1]. Other solvent systems 
were also attempted (e.g. Mobile Phases 1, 7, 8 and 10), but a single spot was always 
obtained, hence it was concluded that this fraction consisted of only one relatively 
pure compound. Similarly, a single peak at a retention time of 16.64 min was also 
obtained on GC/MS using the GC method discussed in Section 2.5.4. However, MS 
data did not help with structural elucidation. The isolated compound (11.3 mg) was 
therefore also subjected to IR, 1H and 13C NMR spectroscopy for structural 
identification. Based on these analyses, the compound was identified as carissone, 
corresponding to information provided in the literature43, 58  for this compound.  
3.4.2 Fraction 3 [#4.3] 
Non-polar solvents systems using varying concentrations of DCM and EtoAc as 
mobile phase were not able to separate any of the compounds present in the 209 mg 
sample. However, a mixture of EtoAc and ethanol (1:1) eluted the compounds from 
silica gel as three major fractions. The second fraction (88 mg) [#4.3.2], which 
contained two major compounds was further separated by preparative TLC with 
ethyl acetate: petroleum ether (7:3) using two separate plates and applying 500µL of 
a 100mg/mL concentrated solution to each. The spot with the lower Rf value (0.45) 
produced a high intensity blue florescence when observed at 366 nm. After its 
isolation, this compound (8.2 mg) remained a single spot when analysed in different 
TLC solvent systems (Table 4). Gas chromatography trace did not show any peaks 
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from the sample, hence it appears to be non-volatile in nature. The sample was 
analysed by FTIR, 1H and 13C NMR spectroscopy for structural identification. The 
compound showed many spectroscopic characteristics of a eudesmane type 
sesquiterpene. For instance, 13C signals for the ketone carbon C-3, as well as the 
methyl groups C-12 and C-15, compare well with other reported eudesmanes 
reported in section 1.5.1, while the obtained infrared spectrum also showed 
similarities with other eudesmanes isolated from Carissa ssp. The exact structure of 
the compound [#4.3.2.1], however, is yet to be identified. The amount recovered was 
insufficient to follow up with further, more detailed structural analysis. Further 
studies and structural elucidation will therefore be an interesting extension of the 
current work. 
 
3.5 Methanol extract [8]  
Tis study mainly concentrated on MeOH extracts of the root wood (Figure 14), since 
they appeared to be abundant in lignans. This was indicated by spraying several TLC 
plates of these extracts with 5% sulphuric acid, which upon heating turned many of 
the identified spots bright red28. 
Using column chromatography, 3.674 g of total MeOH extract of root wood was 
separated over silica gel using EtoAc with increasing MeOH concentrations (10% 
gradient) as mobile phase. After pooling based on identical TLC profiles, four 
fractions were obtained, of which Fraction 1 [#8.1] was further separated using an 
isocratic system of DCM : MeOH (1:1) as mobile phase. Working on the second 
[#8.1.2] of the three major fractions obtained in this procedure, another column 
chromatography using DCM: EtoAc (1:4) as mobile phase was carried out. A 
fraction [#8.1.2.1] containing two major lignans was obtained from these 
experiments. Using MeOH: DCM (2:98) as mobile phase a single compound was 
obtained by yet another column chromatography experiment from its second fraction 
[#8.1.2.1.2], which was further purified by DCM: EtoAc (1:1) over alumina. The 
isolated compound (6.2 mg) was found be a single substance [#8.1.2.1.2.2], as 
confirmed by various TLC experiments conducted in different mobile phases (see 
Table 4). It was subjected to 1H NMR and IR analysis. The obtained spectra matched 
data provided in the literature28, 44 for carinol. The Rf value of 0.38 (0.36-0.39) in 
chloroform: EtoAc (1:4) was reported also in the literature28. 
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  Figure 14:  Isolation path of methanol extracts 
 
 Root wood methanol extract 
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 3.6 Hexane extracts 
Hexane extracts of root wood and bark were studied separately.  
3.6.1 Root bark hexane extract [#3] 
The extract (934 mg) was separated by column chromatography (Figure 15) using a 
gradient system with increasing polarity (hexane, DCM, EtoAc increasing 10% for 
each fraction). After pooling based on their TLC profiles, four fractions were 
obtained, of which Fraction 2 (256 mg) [#3.2] was further analysed. When eluted 
over silica gel, using DCM with increasing concentrations of EtoAc as mobile phase, 
a single compound [#3.2.1] was isolated (61.1 mg), which was purified further by 
DCM on alumina. When studied by TLC in changing mobile phases (Table 4), a 
single spot with a deep green florescence was observed. Spectroscopic analysis and 
GC/MS data indicated a compound of a complex structure, which could not be 
identified within the timeframe of this project. The sample was retained for future 
studies. 
 
Figure 15: Isolation path of root bark hexane extract 
Root bark hexane extract 
3
3.2 3.3 3.4 
Hex>DCM>MeOH  (10%) 
3.1 
3.2.1
DCM>EtOAc (10%) 
Purified 3.2.1
Alumina Column with DCM 
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 3.6.2 Root wood hexane extract [#6] 
An extract of 1.14 g was separated over silica gel by column chromatography using a 
gradient of DCM with increasing concentrations of EtoAc as mobile phase. After 
pooling based on identical TLC profiles, three major fractions were identified, the 
third [#6.3] being similar to compound [#4.2.2.1]. The sample was purified by 
column chromatography over alumina using EtoAc as mobile phase. The resulting 
single compound was further purified over alumina using DCM as the mobile phase. 
Analysis in different TLC systems (Table 4) and GC/MS analysis confirmed this 
compound (3.1 mg) [#6.3] to be pure. Date obtained byGC/MS and 1H-NMR, 
identified the compound as carissone with data matching information provided in the 
literature43 as well as those obtained from compound [# 4.2.2.1] isolated from the 
root wood DCM extract (Section 3.4.1). 
 
Figure 16:  Isolation path of root wood hexane extract  
 Root wood hexane extract 
6
6.2 6.3
DCM>EtOAc (10%) 
6.1
Purified 6.3
Alumina column with EtOAc 
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3.7 Isolated compounds 
 
3.7.1 2′-Hydroxy acetophenone [#1.1] 
 
The volatile liquid obtained by steam distillation and solid phase extraction was 
identified with a high level of confidence (91%) by the HP Chem Search Libraries 
(Wiley 275) as 2′-hydroxy acetophenone (Figure 17-18). This compound has 
previously been isolated from C. edulis by Bentley et al. (1954)45 and is also 
commercially available (Aldrich). Obtained data from 1H NMR of the isolate were 
compared with this reference material and found to be identical. According to its MS 
data, the molecular weight of the substance was found to be 136, which also 
corresponds to the proposed molecular formula of C8H8O2. When treating an 
ethanolic solution of the compound with 10% ethanolic ferric chloride, a deep blue 
coloration confirmed the presence of a phenolic group. With 2, 4-
dinitrophenylhydrazine hydrochloride in MeOH, a yellow colour was formed, 
indicating the presence of a keto functional group.  
 
Figure 17: GC trace of volatile oil  
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Figure 18: Mass spectra for the volatile compound 
 
 
 
 
The fragmentation pattern of the molecule corresponds with the proposed structure 
(Figure 19):  
Fragment m/z 136 represents the intact molecule.  
Loss of a methyl fragment resulted in the base peak of m/z 121 . 
The observed m/z 93 corresponds to the phenolic fragment whereas the plain 
aromatic ring is evident in fragment m/z 77.  
 
Figure 19: Fragmentation pattern of 2'-hydroxy acetophenone 
CH3 O
OH
O
OH O H 
 43
  
 
 
 
 
 
1' 
2' 
5' 3' 
6' 
4' 
2 
1 
CH3 O
OH
Figure 20: Structure of 2′-hydroxy acetophenone 
 
 
 
 
  
 
 
 
Table 8: 1H NMR spectral signal assignments for  
2′-hydroxy acetophenone (Figure 20)  
 
Location of 
Proton 
Number of 
Protons 
δH  
(ppm) 
Appearance 
of signal 
2 3 3.6 s 
3´ 1 7.7 d 
4´ 1 7.4 t 
5´ 1 6.8 dd 
6´ 1 6.9 d 
OH 1 12.2 s 
 
 
 
 
 
 
 
 
There were 4’-, 2’- and 3’-hydroxy substituted acetophenones have been reported 
from various plant sources81. Confirmation of an ortho-substitution pattern for the 
acetophenone derivative isolated in this work can be found in the compound’s 
splitting pattern in its 1H NMR spectrum (Table 8). If the compound were to be meta 
substituted, a singlet for H-2’, duplets for H-4´ and H-6´, as well as a duplet of a 
duplet for H-5´, would have been observed. A para-hydroxyl group, on the other 
hand, would have resulted in a symmetrical molecule with identical signals for H-2´ 
and H-6’ (duplets) as well as for H-3´ and H-5´ (duplets). The obtained spectrum, 
however, shows duplets for H-3´ and H-6´ and duplet of duplets for H-4´ and H-5´, 
which confirms the structure of an asymmetric ortho-substituted acetophenone.  
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3.7.2 Carissone [#4.2.2.1 and #6.3] 
Carissone was previously isolated from C. lanceolata root material by Mohr et al. in 
1954 and also from wood samples by Lindsay et al. (2000)3. Achenbach et al. 
(1985)43 and Rastogi et al. (1967)29 in their work on C. edulis and C. carandas 
respectively have also reported the presence of this compound. The purified 
carissone obtained from this work had a colourless, amorphous appearance. Its Rf 
value in petroleum ether : EtoAc (3:7) was found to be 0.62-0.66, matching data 
(0.65-0.68) provided by Lindsay et al. (2000)3. Spectral data obtained by 1H and 13C 
NMR as well as FTIR spectroscopy for this compound were all in line with data 
reported by Achenbach et al. (1985)43 and Sathe et al. (1971)58 for carissone.  
 
      
11 
15 
OHO
1 
3 
6 
2 
4 
7 
8 
9 
13 
14 
5 
10 
12 
Figure 21: Structure of Carissone 
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Table 9: 1H and 13C NMR spectral assignments of Carissone (Figure 21) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Carbon δC 
(ppm) 
Number of 
Protons 
δH 
(ppm) 
Appearance 
of signal 
1 37.31 2H nic  
2ax 1H  2.51 ddd 
2eq
33.76 
1H  2.38 ddd 
3 199.14 - nic  
4 128.82 - nic  
5 162.75 - nic  
6 ax 1H 1.90 dd 
6 eq
28.72 
1H 2.85 ddd 
7 49.59 1H nic  
8 22.55 2H nic  
9 41.91 2H nic  
10 35.83 - nic  
11 10.87 3H 1.77 d 
12 72.43 - nic  
13 26.69 3H 1.25 s 
14 27.47 3H 1.24 s 
15 22.42 3H 1.19 s 
(nic : Not indicated clearly) 
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 3.7.3 Carinol [8.1.2.1.2.2] 
Carinol was first reported by Pal et al. (1975)28 from C. carandas. Studies on C. 
edulis by Achenbach et al. (1983)44 have also revealed the presence of this lignan. 
Carinol isolated in this work was amorphous in nature and slightly brown in colour. 
TLC studies confirmed a Rf value of 0.38 in EtoAc: chloroform (4:1) in line with 
information published28. Data obtained by 1H NMR spectroscopy and FTIR analysis 
correspond to the spectral values reported28, 44.  
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Figure 22: Structure of Carinol 
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Table 10: 1H and 13C NMR spectral assignments of Carinol (Figure 22) 
Proton Number of protons 
δH  
(ppm) 
Appearance 
of signal 
2 1 6.913 d 
2´ 1 6.909 d 
5 1 
5´ 1 6.871 - 
6 1 6.825 dd 
6´ 1 6.733 dd 
7A 1 
7B 1 
2.588 - 
7´A 1 
7´B 1 
3.000 - 
8 1 2.053  
9A 1 3.709 ddd 
9B 1 3.737 ddd 
9´A 1 3.53 dd 
9´B 1 3.553 dd 
O-Me 3 
O-Me´ 3 3.83 - 
Ar-OH 1 7.35 s 
Ar-OH´ 1 7.33 s 
OH-8´ 1 3.61 s 
OH-9 1 4.42 dd 
OH-9´ OH 4.22 dd 
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3.8 Antibacterial activity 
3.8.1 Antibacterial activity of extracts 
 
Antibacterial assays were performed in triplicates and the average of the obtained 
minimum inhibitory concentration is listed in Table 11. Very low MIC values signal 
high antibacterial activity. Where the extracts’ MIC was higher than 25 mg/mL, 
these were considered inactive65. 
 
Table 11: Minimum inhibitory concentrations of crude extracts 
Extract P. aeruginosa E. coli S. aureus B. subtilis 
Root bark hexane 20 mg/ml no inhibition no inhibition 20 mg/ml 
Root bark DCM 25 mg/ml no inhibition no inhibition 5 mg/ml 
Root bark methanol 2.5 mg/ml 15 mg/ml 25 mg/ml 2.5 mg/ml 
Root wood hexane 20 mg/ml 20 mg/ml 15 mg/ml 25 mg/ml 
Root wood DCM 2.5 mg/ml 10 mg/ml 10 mg/ml 2.5 mg/ml 
Root wood methanol 20 mg/ml 15 mg/ml 15 mg/ml 5 mg/ml 
 
 
Lipophilic constituents of the root bark appear to be less active against the bacterial 
strains studied. The root bark DCM extract exhibited, however, considerable activity 
against B. substilis and also some activity against P. aeruginosa. No inhibition was 
observed with E. coli and S. aureus. MeOH extracts of bark were also active, 
indicating the presence of polar antimicrobial compounds. Compared to root bark 
extracts, root wood extracts displayed stronger antibiosis with the DCM extracts of 
the root wood possessing the highest activity. Considering that the above extracts are 
all multi-compound mixtures, the observed antibacterial activity demonstrated by 
these crude extracts is considerable. In general, all the extracts displayed antibacterial 
activity regardless of the bacterial strain used for the analysis.  Overall, Gram 
negative bacterium, B. subtilise, however, was found to be more susceptible to the 
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extracts, whereas the Gram positive S. aureus and Gram positive E. coli, showed the 
maximum resistance to the studied extracts. 
3.8.2 Antibacterial activity of isolated compounds 
 
Isolated compounds were also tested for their antibacterial activity (Table 12) by 
using serial dilutions of 10mg/mL to 1.25 mg/mL. A minimum inhibitory 
concentration above 10 mg/mL was not considered antibacterial65.  
 
Table 12: Minimum inhibitory concentrations of the isolated compounds 
 
Compound Ps. aeruginosa E. coli S. aureus B. subtilis 
2'-hydroxy 
acetophenone 1.25 mg/ml 1.25 mg/ml 1.25 mg/ml 1.25 mg/ml 
carinol No inhibition 1.25 mg/ml 1.25 mg/ml 1.25 mg/ml 
carissone No inhibition 5 mg/ml 10 mg/ml 5 mg/ml 
The chemical diversity of the isolated compounds makes it difficult to directly 
compare their activity against the different bacterial strains used. However, it appears 
that the phenolic volatile compound, 2'-hydroxy acetophenone, is the most active 
antibacterial compound of the three isolates. The lignan carinol was also active 
against all the studied strains with the exception of P. aeruginosa. The sesquiterpene 
carissone was the least active in direct comparison, yet produced significant activity. 
The study also illustrated that Gram positive P. aeruginosa was more resistant 
towards the isolated compounds compared to the other three strains tested. The other 
Gram positive bacterium, S. aureus, demonstrated more resistance than the two 
Gram negative strains, E. coli and B. subtilis, which showed the highest sensitivity 
against the studied compounds.  
The antibacterial activity of the isolated compare did not correspond well with that 
observed for the crude extracts. All the crude extracts inhibited P. aeruginosa, but of 
the three isolated and identified compounds, only 2'-hydroxy acetophenone was 
found to posses an activity against the growth of P. aeruginosa. E. coli and S. aureus 
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were resistant against the root bark’s DCM and hexane extracts, while carissone, 
which was isolated from the DCM and hexane extracts of the root bark,  exhibited 
significant activity against these two strains. These complex findings simply 
illustrate that antibacterial activity obtained from crude extracts is very difficult to 
evaluate as they constitute multi-compound mixtures. The observed antibacterial 
activity of an extract ultimately depends on the concentrations of its antibacterial 
constituent(s). The antibacterial testing of isolated compounds therefore gives a 
much more accurate reflection of any antibacterial activity present.  
Results from these antibacterial assays confirm that C. lanceolata root bark and 
wood both contain various antibacterial compounds found in the volatile oil, less 
polar lipophilic as well as moderately polar hydrophilic extracts and might therefore 
substantiate some of the traditional medicinal claims of this plant.  
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4 Conclusion 
 
Carissa lanceolata root exhibited considerable anti bacterial activity against both 
Gram negative and Gram positive organisms. Crude extracts of its bark and wood, 
which were analysed separately, demonstrated that polar compounds were more 
active against the four strains of bacteria studied in this project. The root bark was 
found to contain a volatile oil, isolated by steam distillation as well as solid phase 
micro extraction. It consisted of a single compound, which was identified as 2'-
hydroxy acetophenone. The identity of this compound was confirmed by GC/MS and 
1H NMR spectroscopy. After its isolation and identification, 2’-hydroxy 
acetophenone was also tested for its antibacterial properties and, not surprising 
considering its phenolic nature, was found to be highly active (MIC 1.25mg/mL – 
against all the four studied strains). 
From the root bark’s DCM extract, the eudesmane, carissone, was isolated by a 
series of chromatographic experiments and its identity was confirmed by IR, 1H and 
13C NMR spectroscopy. In the antibacterial assays performed with the isolate, 
carissone exhibited activity mostly against the Gram negative B. subtilis and E. coli 
(MIC 5mg/mL); Gram positive strains, however, were inhibited to a lesser extent. 
Two more compounds were isolated from the root’s DCM extract, but conclusive 
structural elucidation and individual antibacterial studies could not be undertaken 
with those within the time frame of this project, particularly as only very small 
quantities were obtained in a pure form.  
A MeOH extract of the root’s wood was also studied with the aim to isolate and 
identify antibacterial compounds. After a series of chromatographic experiments the 
lignan carinol was isolated from the moderately polar fractions of the MeOH extract. 
Its IR and 1H NMR characteristics and its Rf value in chloroform: EtOAc (1:4) 
compare well with data reported in the literature for this compound28.  
Carinol was also tested for its antibacterial properties and was shown to be active 
against E. coli, S. aurues and B. substilis (MIC 1.25 mg/mL), but did not P. 
aeruiginosa.  
In summary, from the isolated compounds, the volatile principle 2'-hydroxy 
acetopheneone showed the highest activity against the four bacterial strains included 
in the antibacterial assays of this work, followed by the lignan carinol and the 
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eudesmane sesquitepene carissone. These findings support many of C. lanceolata 
root’s traditional uses, which appear to be mainly attributable to an antimicrobial 
activity of the plant. Thus this project confirms, to an extent, its traditional use by 
many indigenous Australians communities of Northern Australia as a topical 
antibacterial herbal remedy. 
Micro broth dilution and in association with this, the use of resazurine as an indicator 
was also demonstrated to be a very effective technique for antibacterial studies of 
crude plant extracts and isolated compounds.  
Future studies on the root material should be focused on the two compounds, which 
were isolated in this work but could not be structurally identified nor tested for their 
anti bacterial properties. It would also be of interest to concentrate more strongly on 
the plant’s leaves and twigs, which have not yet been fully explored for their 
chemical constituents and antibacterial activity.  
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Appendices  
Appendix I – Spectroscopic Data of Isolated Compounds
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Figure 0: 1H NMR Spectrum of Carinol [#4.1.2.1.2.2] 
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Figure 31: Infra-Red Spectrum of Carinol [#4.1.2.1.2.2] 
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Appendix II – Reagents  
 
1. Dragendroff’s Reagent 
Preparation:73
Mix 2g of bismuth subnitrate, 25mL of acetic acid and 100 mL of water (a). 
Dissolve 40g of potassium iodide in 100mL of water (b). Mix 10 mL of (a) 
and 10 mL of (b), 20 mL of acetic acid and 100 mL of water. 
 
2. Mayer’s Reagent 
Preparation: 73
Dissolve 1.36g of mercuric chloride in 60 mL of water. Also prepare a 
solution of 5g potassium iodide in 20 mL of water. Mix both solutions and 
make up to 100 mL with water.  
 
3. Anisaldehyde Spray Reagent 
Preparation:73
Dissolve 0.5 mL of anisaldehyde in 10 ml of glacial acetic acid, add 85 mL of 
MeOH and 5 mL of sulphuric acid. 
 
4. Ferric chloride (10%) reagent  
Preparation:72
Iron (III) chloride is dissolved in water to obtain a 10% w/v concentration. 
 
5. Ethanolic ferric chloride (5%) solution 
Preapration: 72
Dissolve Iron (III) chloride in ethanol (95%v/v) to obtain a 5% w/v 
concentration. 
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Appendix III – Method Development for Anti-Microbial Assay 
 
In a preliminary project to this study, three different anti-microbial bioassays (disc 
diffusion, well diffusion and micro-broth dilution) were conducted and their results 
compared using various extracts of Tinospora smilacina, another important 
traditional Aboriginal medicinal plant. As the latter, particularly in combination with 
resazurine as indicator was found to be the most convenient and reliable assay, it was 
adopted as the method of choice for this work. 
 
Tinospora smilacina, which is the Australian member of the genus Tinospora, is also known as 
“Snake Vine” and used in indigenous medicine by various Aboriginal communities in Northern and 
Western Australia. A literature survey revealed that little scientific work has to date been undertaken 
with this particular species, which is in contrast to the well researched Asian members of the family, 
T. cordifolia and T. sinensis. In this study methanol and hexane extracts of T. smilacina as well as 
selected extract fractions separated by column chromatography were subjected to anti-microbial 
activity assays using three different methods, namely disc diffusion, well diffusion and micro-broth 
dilution. One aim was to compare the results obtained with the three methodologies and, based on 
this, assess their suitability for bioassay guided fractionations. Out of the three methods trailed micro-
broth dilution was found to be the most convenient and reliable. Five fractions isolated by column 
chromatography from the methanol extract of the plant showed promising antimicrobial activity, 
particularly against S. aureus, and should be investigated further in a follow up study.  
 
Findings of the above preliminary project were presented at the following research 
symposia: 
 
1. Western Australian Biomedical Research Institute (WABRI), Research 
Symposium (Perth, Australia, 29th April 2005). 
2. Australian Society for Medical Research (ASMR), Research Week 
Symposium (Perth, Australia, 7th June 2005). 
3. Australasian Pharmaceutical Science Association (APSA-ASCEPT) Annual 
Scientific Meeting (Melbourne, Australia, 5th December 2005). 
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Appendix IV – Presentations 
 
 
Antibacterial activity of Carissa lanceolata R.Br. Root. Dhanushka S Hettiarachchi, 
Susanne Schorr & Connie Locher. School of Pharmacy, Curtin University of 
Technology, Western Australia 6152 
 
Carissa lanceolata (Conkerberry) is a perennial woody shrub used in traditional 
medicine by indigenous communities in Western Australia, the Northern Territory 
and Queensland, for various medical conditions such as, toothache, respiratory 
infections, cleaning of sores, which all strongly indicate an antibacterial activity. A 
literature review revealed that the wood of this plant possesses significant 
antibacterial activity, which was found to be related to the presence of eudesmane 
type sesquiterpenes.   
To expand on these findings in the present study the volatile and non-volatile 
constituents of the root of the plant were investigated for their antibacterial activity. 
A volatile oil was isolated from the root bark, both by solid phase extraction and 
steam distillation, which was found to constitute mainly 2-hydroxyacetophenone as 
identified by GC/MS and NMR analyses. MeOH and DCM extracts of the root bark 
and root wood as well as the phenolic 2-hydroxyacetophenone itself showed a 
considerable antimicrobial activity when assayed. A micro-broth dilution assay was 
performed on 96-well plates using resazurin as indicator for the microbial growth, 
against Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis and 
staphylococcus aureus. These extracts were fractionated by column chromatography 
and further separated by preparative TLC in an attempt to identify their antimicrobial 
constituents. 
 
 
Presented to the following research symposia: 
 
 
1. Australian Society for Medical Research (ASMR), Research Week 
Symposium (Perth, Australia, 9th June 2006). 
 
2. 6th International & 16th National Chemistry Conference, Pakistan (Multan, 
Pakistan, 7th April, 2006). 
 
3. Australasian Pharmaceutical Science Association (APSA-ASCEPT) Annual 
Scientific Meeting (Melbourne, Australia, 5th December 2005). 
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